EFFECT OF METFORMIN ON HEART RATE VARIABILITY IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS PATIENTS AT A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i2.46418Keywords:
Autonomic nervous system, Diabetes mellitus, Heart rate variabilityAbstract
Objectives: There is a worldwide epidemic of type 2 diabetes mellitus (T2DM). It is associated with cardiovascular autonomic neuropathy. Heart rate variability (HRV) is the gold standard for its measurement. Thus, effect of metformin therapy on HRV was evaluated in newly diagnosed T2DM patients.
Methods: This was a prospective and observational study carried out from January 2020 to September 2021 in the medicine outpatient department of a tertiary care hospital in Gujarat, India. The study included newly diagnosed T2DM patients of both genders aged 18–70 years. Baseline HRV parameters were recorded by performing electrocardiogram for a fixed duration of 5 min. Follow-up was done after 6 months of metformin 500 mg monotherapy. Time domain analysis was done using square root of mean square of successive R-R interval difference (RMSSD) and frequency domain analysis was done using low-frequency/high-frequency (LF/HF) ratio. Paired t-test was used for analysis. p<0.05 was considered statistically significant.
Results: Total 30 patients were included in the study. The average age of participants was 43.5±4.5 years. The highest number of patients were from age group between 41 and 50 years (33.3%). There were more number of females (56.7%) compared to males (43.3%). There was an increase in the RMSSD value after metformin treatment, but it was not statistically significant (p=0.308). In frequency domain analysis, there was no significant improvement in LF, HF, as well as LF/HF ratio (p=0.655).
Conclusion: There was a minor improvement in HRV parameters after 6 months of metformin therapy, but it was not statistically significant. Further studies with larger sample size should be planned with one or more oral hypoglycemics.
Downloads
References
da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, et al. IDF diabetes atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 2016;117:48-54. doi: 10.1016/j.diabres.2016.04.016, PMID 27329022
Pradeepa R, Mohan V. Epidemiology of Type 2 diabetes in India. Indian J Ophthalmol 2021;69:2932-8. doi: 10.4103/ijo.IJO_1627_21, PMID 34708726
Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015;6:1246-58. doi: 10.4239/wjd. v6.i13.1246, PMID 26468341
Benichou T, Pereira B, Mermillod M, Tauveron I, Pfabigan D, Maqdasy S, et al. Heart rate variability in Type 2 diabetes mellitus: A systematic review and meta-analysis. PLoS One 2018;13:e0195166. doi: 10.1371/journal.pone.0195166, PMID 29608603
Zygmunt A, Stanczyk J. Methods of evaluation of autonomic nervous system function. Arch Med Sci 2010;6:11-8. doi: 10.5114/ aoms.2010.13500, PMID 22371714
Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task force of the European Society of Cardiology and the North American society of pacing and electrophysiology. Circulation 1996;93:1043-65. doi: 10.1161/01. CIR.93.5.1043, PMID 8598068
Kumar HK, Kota S, Basile A, Modi K. Profile of microvascular disease in Type 2 diabetes in a tertiary health care hospital in India. Ann Med Health Sci Res 2012;2:103-8. doi: 10.4103/2141-9248.105654, PMID 23439986
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades- Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1•9 million people. Lancet Diabetes Endocrinol 2015;3:105-13. doi: 10.1016/S2213- 8587(14)70219-0, PMID 25466521
Kilit C, Demir S, Kilit TP, Melek M. The effects of metformin and rosiglitazone on heart rate turbulence in Type 2 diabetes mellitus. J Electrocardiol 2007;40:160. doi: 10.1016/j.jelectrocard.2007.03.160
van den Berg ME, Rijnbeek PR, Niemeijer MN, Hofman A, van Herpen G, Bots ML, et al. Normal values of corrected heart-rate variability in 10-second electrocardiograms for all ages. Front Physiol 2018;9:424. doi: 10.3389/fphys.2018.00424, PMID 29755366
Sammito S, Böckelmann I. Reference values for time-and frequency-domain heart rate variability measures. Heart Rhythm 2016;13:1309- 16. doi: 10.1016/j.hrthm.2016.02.006, PMID 26883166
Nyström T, Santos-Pardo I, Fang X, Cao Y, Hedberg F, Jendle J. Heart rate variability in Type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group study. Endocrinol Diabetes Metab 2019;2:e00058. doi: 10.1002/edm2.58, PMID 31008366
Manzella D, Grella R, Esposito K, Giugliano D, Barbagallo M, Paolisso G. Blood pressure and cardiac autonomic nervous system in obese Type 2 diabetic patients: Effect of metformin administration. Am J Hypertens 2004;17:223-7. doi: 10.1016/j.amjhyper.2003.11.006, PMID 15001195
Published
How to Cite
Issue
Section
Copyright (c) 2022 khushbu rathod, Preeti Yadav, Mayur Chaudhari, Ashvin vasava, Mrugank Patel
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.